These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 8740320

  • 1. Phenytoin protein binding and dosage requirements during acute and convalescent phases following brain injury.
    Markowsky SJ, Skaar DJ, Christie JM, Eyer SD, Ehresman DJ.
    Ann Pharmacother; 1996 May; 30(5):443-8. PubMed ID: 8740320
    [Abstract] [Full Text] [Related]

  • 2. Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients.
    Schleibinger M, Steinbach CL, Töpper C, Kratzer A, Liebchen U, Kees F, Salzberger B, Kees MG.
    Br J Clin Pharmacol; 2015 Sep; 80(3):525-33. PubMed ID: 25808018
    [Abstract] [Full Text] [Related]

  • 3. Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.
    Johnson GJ, Kilpatrick CJ, Bury RW, Fullinfaw RO, Moulds RF.
    Br J Clin Pharmacol; 1989 Jun; 27(6):843-9. PubMed ID: 2503019
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The predictive performances of equations used to estimate unbound phenytoin concentrations in a medical ICU population and the impact of exogenous albumin administration.
    Parikh L, MacLaren R.
    J Crit Care; 2018 Apr; 44():95-100. PubMed ID: 29078132
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the serum protein binding of maprotiline and phenytoin in uraemic patients on haemodialysis.
    Lynn K, Braithwaite R, Dawling S, Rosser R.
    Eur J Clin Pharmacol; 1981 Jan; 19(1):73-7. PubMed ID: 7461027
    [Abstract] [Full Text] [Related]

  • 9. Effect of acute phase response on phenytoin metabolism in neurotrauma patients.
    McKindley DS, Boucher BA, Hess MM, Rodman JH, Feler C, Fabian TC.
    J Clin Pharmacol; 1997 Feb; 37(2):129-39. PubMed ID: 9055139
    [Abstract] [Full Text] [Related]

  • 10. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
    Joerger M, Huitema AD, Boogerd W, van der Sande JJ, Schellens JH, Beijnen JH.
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
    [Abstract] [Full Text] [Related]

  • 11. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
    Kerrick JM, Wolff DL, Graves NM.
    Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Unbound fraction of ertapenem in intensive care unit patients.
    Liebchen U, Kratzer A, Wicha SG, Kees F, Kloft C, Kees MG.
    J Antimicrob Chemother; 2014 Nov; 69(11):3108-11. PubMed ID: 24962030
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of unbound phenytoin concentrations in neurointensive care unit patients using a revised Winter-Tozer equation.
    Kane SP, Bress AP, Tesoro EP.
    Ann Pharmacother; 2013 May; 47(5):628-36. PubMed ID: 23606554
    [Abstract] [Full Text] [Related]

  • 18. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
    Oellerich M, Müller-Vahl H.
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Distribution of antipyrine, phenylbutazone and phenytoin in experimental renal failure.
    Van Peer AP, Belpaire FM, Rosseel MT, Bogaert MG.
    Pharmacology; 1981 Jan; 22(2):139-45. PubMed ID: 7208595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.